BioSpace News Archive

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, announced financial results for the third quarter of 2022 and provided a general business update.

On Wednesday, Nov. 2, Saint Louis University announced the launch of the Institute for Translational Neuroscience.

Mallinckrodt plc announced that seven scientific abstracts on clinical and health economic outcomes research on treatment with TERLIVAZ® for adult patients with hepatorenal syndrome involving rapid reduction in kidney function,1 an acute and life-threatening condition requiring hospitalization2 will be presented at the American Association for the Study of Liver Diseases 2022 Liver Meeting in Washington, DC, from November 4-8.

ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies, announced that Company management will participate in the Stifel 2022 Healthcare Conference.

Athenex, Inc. announced that a Nasdaq Hearings Panel has granted the company’s request for continued listing on The Nasdaq Stock Market, subject to the Company’s satisfaction of the minimum $1.00 bid price requirement by March 14, 2023.

Helius Medical Technologies will showcase its innovative new Portable Neuromodulation Stimulator at the 99th annual American Congress of Rehabilitation Medicine Conference, held November 8-11 in Chicago.

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, announced the appointment of Victor Sandor, M.D.C.M., to its Board of Directors.

C4 Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2022, as well as recent business highlights.

Renalytix plc announced the Company will participate in the Stifel Healthcare Conference to be held November 15-16, 2022 at the Lotte New York Palace Hotel.

Amryt provides a business update and announces unaudited financial results for the third quarter ended September30, 2022.